Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
contributes to aging-related diseases and aims to develop therapeutic strategies to mitigate its harmful effects while preserving its beneficial functions. The lab also works on cellular rejuvenation through
-
teach and continuously develop mandatory and elective courses in the study programs of the Department (BSc and MSc in Biology, One-year MSc in Climate Adaptation), with topics including, for example
-
stakeholders and policy makers. A documented ability to secure external research funding is seen as an asset. We expect the successful candidate to actively engage in the development of the research centre and
-
candidate will be given extensive freedom to pursue personal ideas and to develop the postdoc project individually within the overall frame of the project. To be eligible for the position, the applicant must
-
information from medical images, improvement of image quality to support dose calculation and adaptive treatment delivery, and statistical modeling of patient data as well as development of efficient methods
-
and aim to develop a long-term research plan based on the clinical functions of the department. A particular focus will be on prostate cancer, including areas such as early detection, screening, imaging
-
of responsibility The clinical professor will be responsible for hepatology research and develop new collaboration strategies with other key stakeholders in these areas. Additionally, the clinical professor should
-
and the Department of Psychology. The main tasks will be to apply for, manage, and lead innovative research projects, build and develop research environments around these projects, as well as to support
-
health and midwifery science. The academic position The job involves research, professional development, research education, research-based teaching, including exams, supervision and assessment work within
-
development, and guidance within the field tumor-immunology and cell therapy. The position focuses on in vivo reprogramming of immune cells using chimeric antigen receptor (CAR) constructs against glioblastoma